What are the benefits and limitations of AI in spirometry testing?
There is an increased interest in the potential of Artificial Intelligence to help inform healthcare decision-making.
Spirometry is a key clinical endpoint in trials with a respiratory focus. In this clip, Carl Mottram, Chief Scientific Advisor for Vitalograph gives a concise review of AI in the respiratory field and how it relates to spirometry acceptability and usability criteria.
https://vitalograph.com/wp-content/uploads/2024/02/Carl-AI-clip-20m-1.mp4
Are you interested in finding out more about how Vitalograph can enable your clinical trial success?
Talk with us by filling in the form below. We are also attending SCOPE Summit 2024 in Orlando and would love to chat to you there.
Talk to us
Klinische Studien
Dienstleistungen für klinische Studien
Wir sichern den Erfolg Ihrer Studie mit unserer Expertise in der Atemwegsdiagnostik und innovativen Lösungen für klinische Studien.